During the last session, Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares were 0.63 million, with the beta value of the company hitting 0.75. At the end of the trading day, the stock’s price was $0.24, reflecting an intraday loss of -3.86% or -$0.01. The 52-week high for the CGTX share is $2.54, that puts it down -958.33 from that peak though still a striking 8.33% gain since the share price plummeted to a 52-week low of $0.22. The company’s market capitalization is $14.81M, and the average trade volume was 763.05K shares over the past three months.
Cognition Therapeutics Inc (CGTX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. CGTX has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.1.
Cognition Therapeutics Inc (NASDAQ:CGTX) trade information
Cognition Therapeutics Inc (CGTX) registered a -3.86% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.86% in intraday trading to $0.24, hitting a weekly high. The stock’s 5-day price performance is -24.13%, and it has moved by -44.01% in 30 days. Based on these gigs, the overall price performance for the year is -89.14%.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -16.44%. While earnings are projected to return 52.62% in 2025, the next five years will return 32.88% per annum.
CGTX Dividends
Cognition Therapeutics Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 0.65 million shares, is of AWM INVESTMENT COMPANY, INC.’s that is approximately 1.6224% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.08 million.
Also, the Mutual Funds coming in first place with the largest holdings of Cognition Therapeutics Inc (CGTX) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 1.01 shares. This amounts to just over 1.63 percent of the company’s overall shares, with a $0.24 million market value. The same data shows that the other fund manager holds slightly less at 197.68, or about 0.32% of the stock, which is worth about $47245.0.
